The construction of an overall evaluation method for the clinical efficacy of TCM and western medicine in co-constructing parallel medical records
- Conditions
- precancerous gastric lesions
- Registration Number
- ITMCTR1900002299
- Lead Sponsor
- Beijing Institute of Traditional Chinese Medicine Clinical Epidemiology and Evidence-Based Medicine Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Patients with precancerous lesions of the stomach that conform to the consensus opinion on chronic gastritis in China (2017, Shanghai) and the Kyoto global consensus opinion on helicobacter pylori gastritis; At the same time, the patient had the gastroscope and pathology of the first-grade hospital within three months, and the pathological report was clearly one of atrophy, intestinal metaplasia and epithelial neoplasia (dysplasia);
(2) aged between 30 and 70 years;
(3) The patient or family member knows the content of the study and voluntarily signs the informed consent.
1. Pregnancy or pregnancy preparation;
2. With acute cerebral vascular disease;
3. Surgery, major posttraumatic;
4. Patients with known malignant tumors, severe chronic heart, liver, renal insufficiency, and immune deficiencyhigh grade epithelial neoplasia and more severe cases;
5. The patient has a major mental illness or has difficulty controlling his behavior;
6. The patient can not read, can not understand the informed consent or can not sign the informed consent by themselves.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EBMRecord V1.0;OLGA gastric cancer risk staging rating;tissue grading of gastric mucosa;OLGIM gastric cancer risk staging rating;
- Secondary Outcome Measures
Name Time Method economic indicators;